http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101471891-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H5-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7028 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2013-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2014-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101471891-B1 |
| titleOfInvention | Glucosamine-containing cyclo RGDfK derivatives conjugated with DOTA, a process for the preparation thereof and a nuclear medicine imaging agent and an anticancer agent comprising the same |
| abstract | The present invention relates to a novel nuclear medicine imaging contrast agent or an radiotherapeutic drug compound of formula (2), which contains two cyclic RGDfK peptides in a molecule, which contains glucosamine and lysine, and which contains DOTA as a ligand binding radioactive isotopes, (1), a process for their preparation, and a compound of formula (2). |
| priorityDate | 2013-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 61.